U.S., April 9 -- ClinicalTrials.gov registry received information related to the study (NCT07517354) titled 'Family-Based Moyamoya Susceptibility and Early Detection' on March 28.
Brief Summary: This single-center, prospective, family-based observational cohort study aims to investigate susceptibility to moyamoya disease (MMD) and to develop strategies for early screening in individuals at increased familial risk. The study will enroll three groups: patients with MMD, their first-degree relatives, and healthy controls without a family history of MMD.
The rationale for this study is that MMD has an important genetic component, but genetic susceptibility alone does not fully explain disease onset. Current diagnosis often relies on angiograp...